dr. Nadya Aliza Mulyadi

Clinical Research Coordinator

Aliza is currently the Clinical Research Coordinator for the MetLep Trial at OUCRU Indonesia

Aliza has cultivated a deep interest in infectious diseases and health promotion throughout her academic and professional career. From 2022 to 2023, Aliza worked as the Site Study Coordinator for a phase 1 clinical trial of a modified mRNA COVID-19 vaccine booster at Persahabatan Hospital, where she gained hands-on experience in clinical research on infectious diseases, and served as a Research Assistant, focusing heavily on tuberculosis. Her work included developing Tuberculosis TV, an educational platform aimed at raising awareness and promoting health education about TB. In 2024, Aliza joined OUCRU Indonesia, further aligning her career with her commitment to infectious disease research and public health initiatives.

Timeline

2024

Joined OUCRU Indonesia

2022 – 2024

Research Assistant at Yayasan Riset dan Pelatihan Respirasi Indonesia, under the supervision of Prof. Dr. dr. Erlina Burhan, M.Sc., Sp.P(K), working mostly on TB research.

2022 – 2023

Site Study Coordinator for phase 1 linical trial of modified an mRNA COVID-19 vaccine booster at Persahabatan Hospital, under the Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia

2021

Obtained MD from the Faculty of Medicine Universitas Padjadjaran

2015 – 2019

Pursued Bachelor of Medicine at Faculty of Medicine Universitas Padjadjaran

PELAJARI SELENGKAPNYA

Terkait

Skip to content